Intensive blood-glucose control with sul-fonylureas or insulin compared with con-ventional treatment and risk ofcomplications in subjects with type 2 di-abetes (UKPDS 33). Lancet 352:837–853, 1998 4. Koro CM, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000among U.S. adults diagnosed with type 2diabetes. Diabetes Care 27:17–20, 2004 5. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic dif-ferences in glycemic control of adults withtype 2 diabetes. Diabetes Care 22:403– 408, 1999 6. Inzucchi SE: Oral antihyperglycemic therapy for type 2 diabetes: scientiﬁc re-view. JAMA 287:360–372, 2002 7. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 131:281–303, 1999 8. DeFronzo RA, Goodman AM: Efﬁcacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:541–549, 1995 9. Kirpichnikov D, McFarlane SI, Sowers JR: Metformin: an update. Ann Intern Med 137:25–33, 2002